D. Ackermann

Fundador en

Presidio Medical, Inc.

44 años

65 relaciones

Health Technology

Consumer Services

Finance

Perfil

D.
Michael Ackermann was the founder of Tangible Science, Inc. (founded 2011), Oculeve, Inc. (founded 2012) where the title held was President & Chief Executive Officer from 2012 to 2015, Oyster Point Pharma, Inc. (founded 2015) where the title held was Chairman from 2017 to 2020, Presidio Medical, Inc. (founded 2017) where the title held was Director, and Tarsus Pharmaceuticals, Inc. (founded 2017) where the title held was Chairman from 2017 to 2022.
Current jobs include Chief Executive Officer, CFO & Secretary at Osanni Bio, Inc., Director-Biotechnology at Stanford Byers Center for Biodesign, and Advisor at Vensana Capital Management LLC since 2019.
Former job includes Vice President-Neurostimulation at Allergan, Inc. from 2015 to 2017.
Education includes undergraduate degree from Vanderbilt University and graduate and doctorate degrees from Case Western Reserve University.

Cargos activos de D. Ackermann

Empresas	Cargo	Inicio
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Fundador	01/01/2017
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Corporate Officer/Principal	-
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Consultor / Asesor	01/10/2019

Todos los cargos activos de D. Ackermann

Antiguos cargos conocidos de D. Ackermann.

Empresas	Cargo	Fin
TARSUS PHARMACEUTICALS, INC.	Fundador	02/12/2022
OYSR POIN	Fundador	08/10/2020
ALLERGAN, INC.	Corporate Officer/Principal	01/06/2017
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Director Ejecutivo	11/08/2015
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Fundador	-

Ver el detalle de la experiencia de D. Ackermann.

Formación de D. Ackermann.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de D. Ackermann.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	10
Allergan, Inc. Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Health Technology
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Case Western Reserve University Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Health Technology
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Finance
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis	Health Technology
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Health Technology
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Commercial Services